Renal and brain failure predict mortality of patients with acute-on-chronic liver failure admitted to the intensive care unit


Por: Mendez-Guerrero, Osvely, Calle-Rodas, Daniel A., Cervantes-Alvarez, Eduardo, Alatorre-Arenas, Elisa, Perez-Escobar, Juanita, Navarro-Alvarez, Nalu, Torre, Aldo

Publicada: 1 may 2021 Ahead of Print: 1 ene 2020
Resumen:
Introduction and Objectives: Acute on Chronic Liver Failure (ACLF) is characterized by organ failure and high 28-day mortality. Identifying clinical predictors associated with early mortality could have implications for the treatment of patients with ACLF. Patients and methods: Patients diagnosed with chronic liver failure that developed ACLF based on the EASLCLIF Consortium definition admitted to the Intensive care unit of a tertiary hospital between 2012 & ndash;2018 were included. Bivariate and multivariate Cox regression analyses were performed to identify factors associated with mortality. Results: 148 patients (55% female) were diagnosed with ACLF of which 55% (n = 82) had ACLF grade 3, 28% (n = 41) grade 2 and 17% (n = 25) grade 1. The median age was 54 years (41-63). Hepatitis C virus (HCV) was the most frequent etiology in 29.8% (n = 44) of the patients with bacterial infection being the most predominant precipitant factor in 58.1% (n = 86). Ninety-day global cumulative survival was only 18%. When divided by grade, mortality reached to 10% in ACLF 3. Moreover, in the multivariate Cox regression analysis, renal failure (HR 3.26, 95% CI (2.13 & ndash;4.99), brain failure (HR 1.37, 95% CI 1.09 & ndash;2.04) and male sex (HR 1.62, 95% CI 1.10 & ndash;2.40) were independent predictors of 28-and 90-day mortality. Conclusions: ACLF is a frequent syndrome among chronic liver disease patients. Brain and renal failure are significantly associated with higher mortality and are independent predictors of 28 and 90-day mortality. (c) 2020 Fundaci & oacute;n Cli & acute;nica M & eacute;dica Sur, A.C. Published by Elsevier Espana, S.L.U. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Filiaciones:
Mendez-Guerrero, Osvely:
 Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Department of Gastroenterology, Mexico City, Mexico

Calle-Rodas, Daniel A.:
 Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Department of Gastroenterology, Mexico City, Mexico

Cervantes-Alvarez, Eduardo:
 Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Department of Gastroenterology, Mexico City, Mexico

 PECEM, Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City, Mexico

Alatorre-Arenas, Elisa:
 Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Department of Gastroenterology, Mexico City, Mexico

Perez-Escobar, Juanita:
 Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Department of Gastroenterology, Mexico City, Mexico

Navarro-Alvarez, Nalu:
 Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Department of Gastroenterology, Mexico City, Mexico

 Universidad Panamericana School of Medicine, Campus México, Mexico City, Mexico

 Department of Surgery, University of Colorado Anschutz Medical Campus, Denver, CO, United States

Torre, Aldo:
 Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Department of Gastroenterology, Mexico City, Mexico
ISSN: 16652681
Editorial
Mexican Association of Hepatology, PUNTE DE PIEDRA 150, COLONIA TORIELLO GUERRA, MEXICO, DF CP 14040, MEXICO, México
Tipo de documento: Article
Volumen: 22 Número:
Páginas:
WOS Id: 000661281100009
ID de PubMed: 33091594
imagen Hybrid Gold, Gold

MÉTRICAS